TRV GP III, LLC's Net Worth
$0
Who is TRV GP III, LLC?
TRV GP III, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Jounce Therapeutics, Inc., Voyager Therapeutics, Inc., Nurix Therapeutics, Inc., Global Blood Therapeutics, Inc., Relay Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., and Decibel Therapeutics, Inc..
SEC CIK
TRV GP III, LLC's CIK is 0001637299
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revolution Medicines, Inc. (RVMD) Snapshot price: $41.84
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.60% | -419.90K |
$20.25 | -$8,502,995.25 | 5.1M |
Jun 8
| |||
Form 4
| -21.36% | -1.50M |
—
|
—
| 5.52M |
Feb 24
| |||
Form 4
| -12.46% | -1.00M |
—
|
—
| 7.02M |
Dec 2
| |||
Form 4
| -11.08% | -1.00M |
—
|
—
| 8.02M |
Sep 9
| |||
Form 4
| +2,560.14% | 10.52M |
—
|
—
| 10.93M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $12.87
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -52.09% | -2.00M |
—
|
—
| 1.84M |
Nov 29
| |||
Form 4
| -34.25% | -2.00M |
—
|
—
| 3.84M |
Scheduled
|
Sep 20
| ||
Form 4
| +2,750.00% | 7.69M |
—
|
—
| 7.97M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -16.11% | -750.00K |
—
|
—
| 3.91M |
Aug 16
| |||
Form 4
|
∞
| 4.66M |
—
|
—
| 4.66M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jounce Therapeutics, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -62.32% | -1.90M |
$8.38 | -$15,922,000.00 | 1.15M |
Nov 12
| |||
Form 4
| +2,350.00% | 12.74M |
—
|
—
| 13.28M |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nurix Therapeutics, Inc. (NRIX) Snapshot price: $23.33
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.08% | -1.09M |
—
|
—
| 3.42M |
Scheduled
|
May 6
| ||
Form 4
| -16.86% | -914.22K |
—
|
—
| 4.51M |
Feb 4
| |||
Form 4
|
∞
| 5.42M |
—
|
—
| 5.42M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||